Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 20
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain chemicals...

    Unlock the Secrets of Animals that Survive Freezing!

    The North American wood frog Rana sylvatica can survive being frozen solid - no heartbeat, no brain activity...

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Backer Badge Funded